First to perform TransCarotid Artery Revascularization in Tennessee

Friends of Heart, a fund of the West Tennessee Healthcare Foundation, announces two new procedures that have a powerful impact on heart patients in the West Tennessee area. TCAR and MICRA are two procedures that are cutting edge and the first to be performed in the state of Tennessee.

With the help of Silk Road Medical, Dr. Broussard along with the West Tennessee Heart & Vascular Center (WTHVC) is the first in the state of Tennessee to perform the TransCarotid Artery Revascularization, or TCAR procedure.

TCAR is a new, clinically proven procedure for Carotid Artery Disease that combines surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.

TCAR is a surgically inspired procedure and is designed to reduce the risk of stroke while inserting the stent. During the TCAR procedure, a small incision is made just above the collar bone to expose the common carotid artery. Your surgeon will place a tube directly into your carotid artery and connect it to a system that will direct blood flow away from your brain to protect against plaque that may come loose reaching your brain. Your blood will flow through the system and any material will be captured in a filter outside the body. Your filtered blood will then be returned through a second tube in your upper leg. After the stent is placed successfully, flow reversal is turned off and blood flow resumes in its normal direction.

To learn more about the TCAR procedure visit Silk Road Medical at http://silkroadmed.com/the-tcar-procedure/.

Medtronic MICRA pacemaker is the world’s smallest pacemaker. WTHVC announces this new clinical procedure along with Dr. Osayamen, being the first in the state to place this technology into patients at Jackson-Madison County General Hospital (JMCGH).  This pacemaker is 95% smaller than the current pacemakers and self contained in the heart with no leads required. This new device has a longevity of 12 years. Placement in the patient is minimally invasive with the implantation of a tiny device via a percutaneous, femoral approach (through a vein). This procedure has had a 99% implant success rate with 48% fewer complications.